# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hepatitis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 411-420 of 495 results.
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Status: Recruiting
Last Changed: Oct 19, 2020
First Received: Oct 19, 2020
Disease(s): Hepatitis B, Cirrhosis, Liver, Chronic Liver Disease
Intervention(s): Heplisav-B Injectable Product, 2-dose regimen, Heplisav-B Injectable Product, 3-dose regimen
Locations: Mercy Medical Center, Baltimore, Maryland, United States
Evaluation of Patients With Liver Disease
Status: Recruiting
Last Changed: Dec 03, 2020
First Received: Jan 19, 2000
Disease(s): Hepatitis D, Hepatitis C, Hepatitis B, Liver Disease
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Simplified Monitoring Myanmar SM2 Study
Status: Recruiting
Last Changed: Oct 09, 2019
First Received: Oct 03, 2019
Disease(s): Hepatitis C, Liver Cirrhoses, Liver Inflammation, HIV Infections
Intervention(s): HCV point of care machine
Locations: The Kirby Institute, University of New South Wales Australia, Sydney, New South Wales, Australia
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
Status: Recruiting
Last Changed: May 24, 2011
First Received: May 09, 2011
Disease(s): Cirrhosis, End Stage Liver Disease, Hepatitis C
Intervention(s): Screening
Locations: Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, United States
sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis
Status: Recruiting
Last Changed: Apr 07, 2020
First Received: Oct 05, 2016
Disease(s): Primary Biliary Cirrhosis, Liver Inflammation
Intervention(s): Blood samples, fibroscan and questionaires
Locations: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Denmark, Aarhus C, Region Midtjylland, Denmark
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
Status: Recruiting
Last Changed: Jul 02, 2020
First Received: Jun 07, 2017
Disease(s): Autoimmune Liver Disease, Autoimmune Hepatitis, Primary Sclerosing Cholangitis
Locations: Cincinnati Children's Hospital and Medical Center, Cincinnati, Ohio, United States
MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
Status: Recruiting
Last Changed: Jul 02, 2020
First Received: Jun 05, 2017
Disease(s): Autoimmune Liver Disease, Primary Sclerosing Cholangitis, Autoimmune Hepatitis
Locations: Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States
A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases
Status: Recruiting
Last Changed: Mar 11, 2020
First Received: Mar 11, 2020
Disease(s): HIV, Viral Hepatitis
Locations: Uhmontpellier, Montpellier, France
A Phase IV Study to Assess the Safety of EupentaTM Inj
Status: Not yet recruiting
Last Changed: Aug 14, 2019
First Received: Aug 14, 2019
Disease(s): Hepatitis B, Diphtheria, Haemophilus Influenzae Type B Infection, Tetanus, Pertussis
Intervention(s): Eupenta Inj.
PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders
Status: Recruiting
Last Changed: Apr 21, 2020
First Received: Apr 21, 2020
Disease(s): HCV Infection, Beta Thalassemia Major
Intervention(s): Sofosbuvir and Ledipasvir
Locations: Masri-Crc, Cairo, Egypt